Explore: Biotech · Drug Discovery · Generative AI · Digital Health · Seed
Arch
Arch Venture Partners
ARCH Venture Partners is a leading venture capital firm focused exclusively on early-stage, breakthrough discoveries in life sciences, deep science/physical sciences, and information technology. Their science-first approach involves deep scientific due diligence before company formation, direct co-founding with university researchers and scientists, and long-term commitment with patient capital from concept through growth. They leverage an extended partnership network to build transformative companies.
Arch (Arch Venture Partners) invests at seed, focuses on Biotech, Drug Discovery, Generative AI and Digital Health, backs founders in global.
Stages
Sectors
Geographies
Headquarters
USA
Recently backed startups
🔒 Team & partners
Sign in to view🔒 Live funding signals
Sign in to view🔒 Contacts
Sign in to viewSign in to see Arch's full profile
Team & partners, portfolio, live funding signals and contacts. Free account, Google sign-in.
Create free accountVerified 29 March 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Arch invest in?
- Arch invests in Biotech, Drug Discovery, Generative AI and Digital Health at the seed stage.
- Which geographies does Arch focus on?
- Arch focuses on global, and is headquartered in USA.
- Which startups has Arch backed?
- Arch has 1 tracked investment on Fusion42, including Trase.